{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:04:47Z","timestamp":1789761887861,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000918","name":"New York Community Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000918","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.urolonc.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:54:26Z","timestamp":1786539266000},"page":"556-564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of pelvic lymph node dissection among men undergoing radical prostatectomy in the US: Population-based analysis between 2010 and 2020"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2127-2382","authenticated-orcid":false,"given":"Hriday P.","family":"Bhambhvani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gal","family":"Wald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjile","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Barocas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin H.","family":"Kensler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles M.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Nanus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulla","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Shoag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashir","family":"Al Hussein Al Awamlh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2026.07.009_bib0001","unstructured":"National Comprehensive Cancer Network. Prostate Cancer (Version 1.2025). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf. Accessed April 13, 2025."},{"key":"10.1016\/j.urolonc.2026.07.009_bib0002","doi-asserted-by":"crossref","DOI":"10.1097\/01.ju.0000091805.98960.13","article-title":"A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer","volume":"170","author":"Cagiannos","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0003","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/pros.23292","article-title":"North American population-based validation of the National Comprehensive Cancer Network practice guideline recommendation of pelvic lymphadenectomy in contemporary prostate cancer","volume":"77","author":"Leyh-Bannurah","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0004","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4111\/kju.2012.53.11.755","article-title":"Clinical experience with limited lymph node dissection for prostate cancer in Korea: single center comparison of 247 open and 354 robot-assisted laparoscopic radical prostatectomy series","volume":"53","author":"Choi","year":"2012","journal-title":"Korean J Urol"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7812\/TPP\/17-233","article-title":"Radical prostatectomy and pelvic lymph node dissection in kaiser permanente southern california: 15-year experience","volume":"23","author":"Banapour","year":"2019","journal-title":"Perm J"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0006","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.juro.2014.09.019","article-title":"Variation in pelvic lymph node dissection among patients undergoing radical prostatectomy by hospital characteristics and surgical approach: results from the National Cancer Database","volume":"193","author":"Wang","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0007","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1002\/cncr.25981","article-title":"Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy","volume":"117","author":"Feifer","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0008","unstructured":"National Cancer Institute. Prostate cancer with additional treatment and risk stratification fields database. Surveillance, Epidemiology, and End Results Program. https:\/\/seer.cancer.gov\/data\/specialized\/available-databases\/prostate-request\/; Accessed on June 1, 2025."},{"key":"10.1016\/j.urolonc.2026.07.009_bib0009","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.eururo.2020.01.009","article-title":"The new surveillance, epidemiology, and end results prostate with watchful waiting database: opportunities and limitations","volume":"78","author":"Jeong","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0011","unstructured":"Memorial Sloan Kettering Cancer Center. (n.d.). Pre-radical prostatectomy nomogram. MSKCC prostate cancer nomograms. Retrieved on June 5, 2025, from https:\/\/www.mskcc.org\/nomograms\/prostate\/pre_op"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0012","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.clgc.2021.01.005","article-title":"Contemporary national trends and variations of pelvic lymph node dissection in patients undergoing robot-assisted radical prostatectomy","volume":"19","author":"Xia","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0013","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (Propsma): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0014","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","article-title":"Diagnostic accuracy of 68ga-psma-11 pet for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 imaging trial","volume":"7","author":"Hope","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0015","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/JU.0000000000004821","article-title":"Decision analysis of pelvic lymph node dissection during radical prostatectomy","volume":"215","author":"Vickers","year":"2026","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0016","doi-asserted-by":"crossref","first-page":"e1001","DOI":"10.1016\/j.clgc.2017.05.013","article-title":"Utilization of pelvic lymph node dissection for patients with low-risk prostate cancer treated with robot-assisted radical prostatectomy","volume":"15","author":"Modi","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0017","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5489\/cuaj.3563","article-title":"Suboptimal use of pelvic lymph node dissection: differences in guideline adherence between robot-assisted and open radical prostatectomy","volume":"10","author":"Schiffmann","year":"2016","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0018","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CU9.0000000000000132","article-title":"Differences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registries","volume":"16","author":"Flammia","year":"2022","journal-title":"Curr Urol"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0019","doi-asserted-by":"crossref","first-page":"47.e1","DOI":"10.1016\/j.urolonc.2013.06.013","article-title":"Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?","volume":"32","author":"Kluth","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0020","first-page":"20","article-title":"Complications of pelvic lymphadenectomy: do the risks outweigh the benefits?","volume":"12","author":"Loeb","year":"2010","journal-title":"Rev Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.07.009_bib0021","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.eururo.2025.03.004","article-title":"Pelvic lymph node dissection in prostate cancer: evidence and implications","volume":"87","author":"Roberts","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0022","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11934-011-0179-z","article-title":"Complications of pelvic lymph node dissection for prostate cancer","volume":"12","author":"Keegan","year":"2011","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0023","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","article-title":"Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial","volume":"79","author":"Lestingi","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0024","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.euo.2021.03.006","article-title":"Limited versus extended pelvic lymph node dissection for prostate cancer: a randomized clinical trial","volume":"4","author":"Touijer","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.07.009_bib0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2024.10.006","article-title":"Pelvic lymph node dissection in prostate cancer: update from a randomized clinical trial of limited versus extended dissection","volume":"87","author":"Touijer","year":"2025","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.009_bib0026","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12253-017-0349-5","article-title":"Is more always better? An assessment of the impact of lymph node yield on outcome for clinically localized prostate cancer with low\/intermediate risk pathology (Pt2-3a\/pn0) managed with prostatectomy alone","volume":"25","author":"Seyedin","year":"2019","journal-title":"Pathol Oncol Res"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926006101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926006101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:12:19Z","timestamp":1789758739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926006101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1078143926006101"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.07.009","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of pelvic lymph node dissection among men undergoing radical prostatectomy in the US: Population-based analysis between 2010 and 2020","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}